An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide

We have previously identified the novel Cancer/Testis antigen PASD1 by immunoscreening a testis library with pooled acute myeloid leukemia (AML) patient sera. To develop a cytotoxic T lymphocyte (CTL)-inducing vaccine, we have now investigated the carboxy-terminal region, known to contain serologica...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hardwick, Nicola, Buchan, Sarah, Ingram, Wendy, Khan, Ghazala, Vittes, Gisella, Rice, Jason, Pulford, Karen, Mufti, Ghulam, Stevenson, Freda, Guinn, Barbara-ann
Format: Artigo
Idioma:Inglês
Publicat: Academy of Cancer Immunology 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3718735/
https://ncbi.nlm.nih.gov/pubmed/23882161
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars